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https://doi.org/10.1016/j.celrep.2020.107641SUMMARYN6-methyladenosine (m6A) is an RNAmodification well-known for its contribution to different processes con-
trolling RNAmetabolism, including splicing, stability, and translation ofmRNA. Conversely, the role ofm6A on
the biogenesis and function of circular RNAs (circRNAs) has yet to be addressed. circRNAs belong to a class
of covalently closed transcripts produced via a back-splicing reaction whereby a downstream 50 splice donor
site fuses to an upstream 30 splice acceptor site. Starting from circ-ZNF609 as a study case, we discover that
specificm6As control its accumulation and that METTL3 and YTHDC1 are required to direct the back-splicing
reaction. This feature is shared with other circRNAs because we find a significant direct correlation among
METTL3 requirement, YTHDC1 binding, and the ability of m6A exons to undergo back-splicing. Finally,
because circ-ZNF609 displays the ability to be translated, we show that m6A modifications, through recog-
nition by YTHDF3 and eIF4G2, modulate its translation.INTRODUCTION
N6-methyladenosine (m6A) is the most abundant internal modifi-
cation of coding and non-coding RNA polymerase II transcripts,
and the one with the greatest impact on their dynamic regulation.
m6A modification is deposited by the core heterodimeric com-
plex composed by methyltransferase-like-3 (METTL3) and -14
(METTL14), with METTL3 being the sole catalytic subunit, and
it can be reversed by the m6A demethylases FTO and ALKBH5
(Zaccara et al., 2019).
m6A can control any aspect of mRNA post-transcriptional
regulation, including splicing, export, stability, and translation
(Zaccara et al., 2019). This is achieved either by producing
conformational changes within local RNA structures or by re-
cruiting specific m6A-reader proteins (Patil et al, 2018; Zaccara
et al., 2019). In particular, YTH domain-containing proteins
were the first readers to be identified. In human there are four
YTH proteins in the cytoplasm (YTHDF1–3 and YTHDC2) and
one in the nucleus (YTHDC1). Whereas YTHDFs and YTHDC2
were shown to control mRNA stability and translation, YTHDC1
was demonstrated to regulate pre-mRNA splicing and export
(Zaccara et al., 2019). More recently, cytoplasmic YTH readers
were also shown to favor the phase separation of m6A-modified
RNAs in membraneless compartments, such as stress granules
and P-bodies (Ries et al., 2019).This is an open access article undDuring the splicing reaction, many pre-mRNAs can produce
covalently closed circular RNAs (circRNAs), whereby a down-
stream 50 splice donor site is fused to an upstream 30 splice
acceptor site in a so-called back-splicing reaction (Ashwal-Fluss
et al., 2014), which is alternative to linear splicing. An open ques-
tion is how the choice between the back-splicing and the linear
splicing is controlled. Using circ-ZNF609 as a study case, we
discovered that m6A modification at specific sites can be a key
element for the modulation of the two alternative pathways.
Furthermore, we show that the biogenesis of a subset of
circRNAs specifically requires METTL3 and YTHDC1 proteins.
circ-ZNF609 is an interesting example to study because high
expression levels correlate with proliferative conditions in human
myoblasts and in rhabdomyosarcoma tumors,whereas its deple-
tion decreases proliferation in both systems (Legnini et al., 2017;
Rossi et al., 2019). circ-ZNF609 contains an open reading frame
(ORF) and can be translated into two proteins using two alterna-
tive START codons, in a splicing-dependent and cap-indepen-
dent manner by a still unidentified mechanism. Here we show
that, in addition to their role in circRNAbiogenesis,m6Amodifica-
tions on circ-ZNF609 play a relevant role in its cap-independent
translation. In particular, we identified YTHDF3 and eIF4G2
proteins as important factors for mediating such a process. Alto-
gether, these data reveal the important contribution of m6A
modifications to circRNA biogenesis and function.Cell Reports 31, 107641, May 12, 2020 ª 2020 The Authors. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
A B C
Figure 1. METTL3 Knockdown Affects circRNA Levels
(A) Levels of circular (circ-ZNF) and linear messenger (lin-ZNF) ZNF609 RNAs recovered from immunoprecipitation with anti-m6A antibody in HeLa cells ex-
pressed as percentage of input with standard deviation. WTAP and ATP5O mRNAs were used as positive and negative controls, respectively; immunopre-
cipitation with IgG was used as control. n = 3.
(B) Relative RNA levels of circ-ZNF, lin-ZNF, and precursor (pre-ZNF) ZNF609 RNAs upon METTL3 knockdown (si-M3) in HeLa cells. Values were normalized
against ACTN1 and expressed as relative quantity with respect to scramble siRNA (si-scr) treatment set to a value of 1. WTAP and ANKIB1 RNAs were used as
positive and negative controls, respectively. n = 3. The relative RNA quantity in the bars is represented as mean of the fold change with standard deviation. Dots
represent the quantity relative to the endogenous control for each biological replicate. The ratio of each sample versus its experimental control was tested by two-
tailed Student’s t test. Student’s t test-derived p values: *p < 0.05; **p < 0.01; ***p < 0.001.
(C) A table with the number of circRNAs and linear RNAs deregulated upon METTL3 knockdown is reported (p < 0.1). For each circRNA identified in the RNA-seq
experiment, the log2 fold change in METTL3 knockdown along with that of its cognate linear RNA is shown in the scatterplot in Figure S1F.
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METTL3 Knockdown Affects circRNA Levels
Similar to mRNAs, circRNAs were shown to be decorated with
m6A modifications and often to derive from exons that have a
differentmethylation pattern inmRNAs (Zhou et al., 2017). By per-
forming m6A CLIP (crosslinking immunoprecipitation; Figure 1A),
we found that circ-ZNF609 and its linear cognate, lin-ZNF609,
were enriched in the m6A-modified fraction, as observed for
WTAP, usedas thepositive control (Sorci et al., 2018). Thereupon,
we analyzed the effects of the downregulation of the main m6A
writer, METTL3 (Zhao et al., 2017), on the accumulation of the
linear and circular transcripts originating from the ZNF609 locus.
Three different small interfering RNAs (siRNAs) against METTL3
were tested separately or in combination in HeLa cells, and all
proved to be effective (Figure S1A); moreover, dot blot analysis
showed that, upon METTL3 depletion with the mix of the three
siRNAs (si-M3), a decrease of the overall m6A levels in total RNA
was obtained (Figure S1B). Upon METTL3 depletion with si-M3
(Figure S1C), we observed a strong and specific decrease of
circ-ZNF609accumulation (Figure 1B). The same resultswere ob-
tained by using the three different siRNAs excluding possible off-
targeting effects (Figure S1D). Unlike the circRNA, the amount of
the linear ZNF609 and WTAP transcripts increased (Figure 1B),
as already described for many m6A-modified mRNAs whose sta-
bility is known to be negatively regulated by m6A modification
(Roignant and Soller, 2017; Zhao et al., 2017). Interestingly, the
downregulation of circ-ZNF609was accompanied by an increase
in the levels of its unspliced precursor RNA, suggesting that the
decrease in methylation could somehow affect the conversion
of the pre-mRNA into the circRNA (Figure 1B).
Actinomycin D pulse chase experiments demonstrated that
METTL3 depletion did not have any effect at the level of the2 Cell Reports 31, 107641, May 12, 2020circRNA half-life (Figure S1E); moreover, it confirmed that the
circRNA has a higher stability than its linear counterpart.
Altogether, these data suggest a role of METTL3 and m6A in
the regulation of the back-splicing reaction, which leads to
circ-ZNF609 biogenesis.
In order to understand whether this feature could be extended
to other circRNAs, we performed RNA sequencing (RNA-seq) on
HeLa cells depleted for METTL3. A total of 3,919 circRNAs were
identified (Table S1), and among them 668 were deregulated
(17%): 442 (66%) were downregulated, whereas 226 (34%)
were upregulated (Figure 1C; Figure S1F; Table S1). Coherently,
circ-ZNF609 was found in the downregulated group (Table S1).
Differential expression analysis revealed that upon METTL3
knockdown, only 18.6% of the deregulated circRNAs had their
linear counterparts significantly varying in the same direction
(concordant; Figure 1C), suggesting that for the majority of
circRNAs, the change in expression levels might not be associ-
ated to transcriptional regulation of their host gene. Furthermore,
inmost caseswhere the circRNA and its linear cognate displayed
discordant variations, the linear isoform showed no significant
changes, suggesting a specific effect on circRNA production.
In order to investigate the involvement of m6A in circRNA
biogenesis, we focused only on discordant circRNAs downregu-
lated upon METTL3 depletion.
YTHDC1 Affects Back-Splicing
Because YTHDC1was shown to be am6A reader regulating pre-
mRNA splicing (Hartmann et al., 1999; Xiao et al., 2016), we
tested its involvement in the back-splicing of circ-ZNF609.
YTHDC1 knockdown in HeLa cells with two different siRNAs
(Figure S2A) resulted in a consistent decrease of circ-ZNF609,
paralleled by the increase of its precursor transcript, whereas
the level of the corresponding linear mRNA remained unaltered
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Figure 2. YTHDC1 Affects Back-Splicing
(A) Relative RNA levels of circ-ZNF, lin-ZNF, and pre-ZNF ZNF609 RNAs upon YTHDC1 knockdown (si-YC1) in HeLa cells; values were normalized against b-
Actin (ACTB) and expressed as relative quantity with respect to si-scr treatment set to a value of 1. n = 3.
(B) A table with the number of deregulated circRNAs and linear RNAs upon YTDC1 knockdown is reported (p < 0.1). For each circRNA identified in the RNA-seq
experiment, the log2 fold change in YTHDC1 knockdown along with that of its cognate linear RNA is shown in the scatterplot in Figure S3C.
(C) Venn diagram showing the overlap between circRNAs downregulated upon METTL3 knockdown and those downregulated upon YTHDC1 knockdown. Only
downregulated circRNAs identified with at least two counts in both METTL3/YTHDC1 knockdown or control samples and whose linear counterpart was not
downregulated were used for this analysis. Significance was calculated via Fisher’s exact test (left panel). Bar plot depicting the percentage of circRNAs
downregulated upon METTL3 and/or YTHDC1 knockdown, which are also precipitated by YTHDC1 and m6A RIP (enriched YTHDC1/m6A). The three bars
represent the circRNAs exclusively downregulated upon METTL3 or YTHDC1 knockdown (METTL3 KD and YTHDC1 KD), as well as those that are affected by
both knockdowns (overlap). p values for the differences between proportions were calculated using Pearson chi-square test with Yates continuity correction
(right panel).
(D and E) Relative RNA levels of selected circRNAs showing decrease either upon METTL3 (D, si-M3) or YTHDC1 (E, si-YC1) knockdown. circ-PMS1 and circ-
ANKIB1 were used as negative controls in METTL3 or YTHDC1 knockdown, respectively. Values were normalized against ACTN1 or ACTB and expressed as
relative quantity with respect to si-scr treatment set to a value of 1. n = 3.
(A–E) The relative RNA quantity in the bars is represented as mean of the fold change with standard deviation. Dots represent the quantity relative to the
endogenous control for each biological replicate. The ratio of each sample versus its experimental control was tested by two-tailed Student’s t test. Student’s t
test-derived p values: *p < 0.05; **p < 0.01; ***p < 0.001.
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different cell lines (RD, RH4, and HEK293T), indicating that
YTHDC1 regulation of circ-ZNF609 accumulation is cell type in-
dependent (Figures S2C and S2D).
Because YTHDC1 is known to have a role in the export of
circRNAs (Chen et al., 2019), we tested whether the observed
decrease of circ-ZNF609 could be due to a nuclear retention.
As indicated in Figure S2E, the subcellular localization of circ-
ZNF609 was not altered upon YTHDC1 depletion. Moreover,
actinomycin D pulse chase experiments demonstrated that
YTHDC1 depletion did not have any effect at the level of circRNA
stability (Figure S2F). These results showed the relevance of
YTHDC1 on circ-ZNF609 biogenesis and indicated that its levelsare limiting for the back-splicing reaction, while not affecting
either the export or the stability of the circRNA. Notably, because
circ-ZNF609 levels are increased in pathological conditions
where proliferation predominates above differentiation such as
rhabdomyosarcoma (Rossi et al., 2019), we tested the levels of
YTHDC1 in these different rhabdomyosarcoma cellular systems
and found a direct correlation between circ-ZNF609 and
YTHDC1 levels (Figure S2G).
Analysis of YTHDC1 RIP-seq (RNA immunoprecipitation and
sequencing) data performed in HeLa cells (Roundtree et al.,
2017) indicated that 78% of circRNAs, including circ-ZNF609,
were enriched more than 2-fold in the immunoprecipitated frac-
tion over the input, whereas such enrichment was not mirroredCell Reports 31, 107641, May 12, 2020 3
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OPEN ACCESSby their linear counterparts (Figure S2H). Alongside, we found
that a significant fraction of circRNAs bound by YTHDC1
(40.5%) was also present in the m6A-modified RNA pool in
HeLa cells (Zhou et al., 2017) (Figure S3A), whereas the overlap
with circRNAs devoid of m6A residues was lower than expected
by chance (Figure S3B). Altogether, these data indicated a signif-
icant correlation between m6A deposition and YTHDC1 binding
to exons that undergo circularization.
We then performed RNA-seq in HeLa cells interfered for
YTHDC1 (Figure S2A). A total of 4,809 circRNAs were identified,
and among them 760 were deregulated (Table S1). Similar to
what was observed in METTL3 depletion, the number of down-
regulated circRNAs (482) was greater than that of the upregu-
lated ones (278; Table S1; Figure 2B; Figure S3C).
circRNAs downregulated upon YTHDC1 knockdown signifi-
cantly overlapped with those precipitated both in YTHDC1
(Roundtree et al., 2017) and in m6A RIP (Zhou et al., 2017, Fig-
ure S3D), reinforcing the idea of a positive effect of YTHDC1
on m6A-circRNA biogenesis. Instead, no significant overlap
was observed between the upregulated and the YTHDC1/m6A-
enriched circRNAs (Figure S3E). A small yet significant fraction
of the downregulated circRNA species in YTHDC1 knockdown
were in common with those decreasing upon METTL3 depletion
(Figure 2C, left panel), suggesting that METTL3 and YTHDC1
could act on the same pathway to favor circRNA biogenesis.
Moreover, circRNAs downregulated uponMETTL3 and YTHDC1
knockdownwere also enriched in YTHDC1 andm6ARIP (Round-
tree et al., 2017; Zhou et al., 2017) if compared with those
affected independently by METTL3 or YTHDC1 (Figure 2C, right
panel). On the other hand, the overlap between the circRNAs up-
regulated upon METTL3 and YTHDC1 depletion was not signifi-
cant (Figure S3F).
We randomly selected a few circRNAs downregulated accord-
ing to RNA-seq data performed upon METTL3 and YTHDC1
knockdown for quantitative RT-PCR validation. Figures 2D and
2E demonstrate that all of these circRNAs are downregulated
upon the depletion of METTL3 and YTHDC1, respectively,
similar to circ-ZNF609. According to RNA-seq data, circ-PMS1
and circ-ANKIB1, unaffected by METTL3 or YTHDC1 depletion,
respectively, were used as negative controls. Interestingly, also
in these cases, with the exception of circ-TET2, the decrease
of the mature circRNA was paralleled by the increase of the pre-
cursor species in both METTL3 and YTHDC1 knockdown (Fig-
ures S3G and S3H). The analysis of the linear counterparts
showed some variability upon depletion of METTL3 (Figure S3I),
whereas a more homogeneous behavior was observed upon
YTHDC1 depletion (Figure S3J). Finally, similar to what was
observed for circ-ZNF609, YTHDC1 knockdown did not cause
any circRNA mislocalization (Figure S2E), excluding possible
circRNA degradation due to nuclear retention. Altogether, these
data indicate that YTHDC1 acts in promoting circularization of a
specific class of circRNAs.
METTL3/YTHDC1-Affected circRNAs Display Specific
m6A Signatures
In order to test whether the exons whose circularization is
controlled by METTL3 and YTHDC1 could possess a distinctive
signature of m6A, we analyzed m6A CLIP data obtained in HeLa4 Cell Reports 31, 107641, May 12, 2020cells by comparing nucleoplasmic and cytoplasmic total RNA
with cytoplasmic poly(A+) RNA (Ke et al., 2017). Because
circRNAs should be depleted in the poly(A+) fraction, the m6As
present only in total RNA preparations (defined as ‘‘total-only
m6As’’) can represent a bona fide circRNA signature.
Interestingly, circRNAs containing total-only m6As were more
represented among those decreasing upon depletion of both
YTHDC1 and METTL3 compared with those affected by either
METTL3 or YTHDC1 knockdown alone; moreover, this was
found in both cytoplasmic and nucleoplasmic total RNA fractions
(Figure 3A). This correlation suggests the hypothesis that the to-
tal-onlym6A signature is established in the nucleus and could act
as a hallmark for METTL3/YTHDC1-dependent circRNA
biogenesis.
In the same dataset, with regard to the exon from which circ-
ZNF609 derives, we observed several m6A modifications.
Among them, them6As referred to as a, b, and gwere exclusively
found in the nucleoplasmic and cytoplasmic total RNA fractions
(Figure 3B), thus belonging to total-only m6As.
Specific m6As Control circ-ZNF609 Biogenesis
To gain further insights into the role of the m6As decorating circ-
ZNF609, we took advantage of an artificial construct, p-circ,
which allows the overexpression of circ-ZNF609 RNA in the
absence of its natural flanking introns (Legnini et al., 2017) (Fig-
ure 4A). Similar to the endogenous molecule, circ-ZNF609
derived from p-circ carried m6A modifications (Figure 4B), and
its accumulation decreased both upon METTL3 (Figure 4C)
and YTHDC1 (Figure 4D) downregulation (Figures S4A and
S4B). Notably, as for the endogenous species, YTHDC1 deple-
tion also produced a significant increase of the unspliced precur-
sor (Figure 4D), indicating that YTHDC1 levels were limiting also
for the transcript deriving from p-circ.
Point mutations were then introduced at ‘‘As’’ corresponding
to m6A CLIP peaks, displaying either optimal m6A consensus
motifs or conservation in murine and human ZNF609 exon 2
sequence (Figure 4A). As control, we raised a mutant at position
1 (c-D1), a canonical m6A site that was not conserved and meth-
ylated in them6ACLIP dataset (Ke et al., 2017). All of the different
constructs, when transfected in HeLa cells, produced unspliced
poly(A+) precursor transcripts, as well as the monomeric circ-
ZNF609; importantly, we never observed the production of linear
concatemers (Figure S4C). Single mutations at the control site 1
(c-D1), as well as at m6A sites 2 and 3, present also in the poly(A+)
fraction (c-D2 and c-D3), did not show any relevant effect on
circRNA accumulation, whereas double mutation at the a and
b sites (c-Da.b) had a slight effect (15%–20%; Figure 4E). Inter-
estingly, when mutating the a and b m6A sites in combination
with the site at position 2 (c-Da.b.2), we observed a dramatic
drop of circRNA level (>80%) that was paralleled by a strong in-
crease in the precursor RNA (Figure 4E), features that mirrored
the endogenous situation observed upon YTHDC1 knockdown.
These data showed the relevance of a and b sites for circ-
ZNF609 biogenesis and indicated that, in combination with the
methylation at position 2, they strongly promote the back-
splicing reaction.
As a control, we analyzed the effect of the samemutations in a
vector overexpressing the sequence of circ-ZNF609 in a linear
AB
Figure 3. METTL3/YTHDC1-Affected circRNAs Contain Specific m6A Signatures
(A) Bar plots depicting the fraction of downregulated circRNA exonic sequenceswithin whichm6A-CLIP identified at least onem6A antibody-enriched RNA region
on total RNA from nucleoplasm (right) or cytoplasm (left) absent in poly(A)+ RNA from cytoplasm. The three bars represent the circRNAs exclusively down-
regulated upon METTL3 KD or YTHDC1 KD, as well as those that are affected by both knockdowns (overlap). p values for the differences between proportions
were calculated using Pearson chi-square test with Yates continuity correction.
(B) m6A sites in the exon producing circ-ZNF609 identified via m6A CLIP performed on total RNA from nucleoplasm (nucleoplasm, total) and cytoplasm (cyto-
plasm, total) or on poly(A+) RNA from cytoplasm [cytoplasm, poly(A)+]. A schematic representation of the second exon of ZNF609 is shown below. 50 UTR, coding
sequence (CDS), and flanking introns (50-intr, 30-intr) are indicated. White circles indicate the m6A sites selected for mutation; blue or red boxes highlight peaks
present or not in the poly(A)+ fraction, respectively.
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OPEN ACCESSconformation, with a cap and a poly(A) tail (p-lin, see schematic
representation in Figure S4D) (Legnini et al. 2017). Notably, also
the transcript originating from p-lin was enriched in the m6A
immunoprecipitation (Figure S4E). However, when D2 and
Da.b.2 mutations were introduced in p-lin, no variation was
observed in the levels of the linear transcript (Figure 4F). Finally,
when RNAs deriving from p-circ and c-Da.b.2 were analyzed in
cells downregulated for YTHDC1 (Figure S4B), only the wild-
type transcript and not the mutant one displayed a clear respon-
siveness to the lack of such factor (Figure 4G), indicating that the
identified m6A sites are indeed sufficient for YTHDC1 activity in
promoting back-splicing.
m6As Control circ-ZNF609 Translation
circ-ZNF609 was previously shown to possess an ORF and to
be able to undergo translation in a cap-independent manner
(Legnini et al., 2017). We previously reported that an artificial
in-vitro-synthesized circ-ZNF609, devoid of any modification,
was unable to drive translation when transfected in HeLa cells
(Legnini et al., 2017). Because m6A modifications were shown
to enable cap-independent translation (Coots et al., 2017; Meyer
et al., 2015; Zhou et al., 2015), we examined their effect on circ-
ZNF609. Proteins deriving from p-circ upon downregulation of
METTL3 were analyzed by western blot. The evaluation of the
effect of METTL3 downregulation on translation, although
challenging because of the 60% decrease in circ-ZNF609 levels,appeared nevertheless higher at the protein level, reaching a
further 20% decline (Figure S4A). This indicated a possible
METTL3-dependent regulation of circ-ZNF609 translation.
In order to obtain data regarding the m6A-dependent trans-
lational regulation of circ-ZNF609, we analyzed proteins from
the same experiment shown in Figure 4E by western blot
with an anti-FLAG antibody. The results showed that c-D2,
c-D3, and c-Da.b mutants displayed approximately a 50%
reduction of translation when compared with p-circ or c-D1
(Figure 5A; Figure S5A), despite producing a comparable
amount of circRNA (Figure 4E). The c-Da.b.2 mutant displayed
a strong decrease in protein production; however, due to the
drastic drop in circRNA level, we could not unambiguously
quantify the effect of such modifications on translation (Fig-
ure 5A; Figure S5A).
The p-lin vector expresses a transcript containing the ORF of
circ-ZNF609 in a linearized conformation (Figure S4D), able to be
translated in a cap-dependent manner. Notably, no translational
effects were detected when selected mutations (D2 and Da.b.2)
were introduced in p-lin (Figure 5B; Figure S5B). These data indi-
cate a specific function of m6A in controlling translation of a cir-
cular molecule.
Due to their known role in modulating mRNA stability and
translation, we tested the effects of the main YTHDF factors
(1, 2, and 3) (Shi et al., 2017) on the accumulation and translation
of circ-ZNF609 derived from p-circ.Cell Reports 31, 107641, May 12, 2020 5
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Figure 4. Specific m6As Control circ-ZNF609 Biogenesis
(A) Schematic representation of the p-circ construct and the corresponding circRNA. Capital letters indicate the position of the primers used for the amplification
of the mature product (A and B) or of the precursor (B and C).
(B) Levels of the transcript expressed from the p-circ construct in HeLa cells recovered from IP with anti-m6A antibody, expressed as percentage of input. WTAP
and ATP5O mRNAs were used as positive and negative controls, respectively; immunoprecipitation with IgG was used as control. n = 3.
(C) Relative RNA levels of the circular transcript deriving from p-circ upon METTL3 knockdown (si-M3) in HeLa cells. Values were normalized against ACTB and
expressed as relative quantity with respect to si-scr treatment set to a value of 1. n = 3.
(D) Relative RNA levels of the circular transcript (p-circ) and the precursor (precursor) deriving fromp-circ uponYTHDC1 knockdown (si-YC1) in HeLa cells. Values
were normalized against ACTB and expressed as relative quantity with respect to si-scr treatment set to a value of 1. n = 3.
(E and F) Mutations were introduced at the m6A consensus sequences in p-circ and p-lin constructs. Relative RNA levels of circular transcripts and precursor
transcripts derived from p-circ (E) and the linear RNA deriving from p-lin (F), as well as from their mutant derivatives, are shown. Values were normalized against
ACTB and expressed as relative quantity with respect to wild-type constructs set to a value of 1. n = 3.
(G) Relative RNA levels of the circular transcript deriving from either p-circ (already shown in Figure 4D) or c-Da.b.2 mutant construct upon YTHDC1 knockdown
(si-YC1) in HeLa cells. Values were normalized against ACTB and expressed as relative quantity with respect to si-scr treatment set to a value of 1. n = 3.
(A–G) The relative RNA quantity in the bars is represented as mean of the fold change with standard deviation. Dots represent the quantity relative to the
endogenous control for each biological replicate. The ratio of each sample versus its experimental control was tested by two-tailed Student’s t test. Student’s t
test-derived p values: *p < 0.05, **p < 0.01, ***p < 0.001.
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OPEN ACCESSThe depletion of YTHDF1/2 had no effect on circ-ZNF609
translation (Figures 5C and 5D; Figures S5C and S5D), whereas
that of YTHDF3 produced a 40% decrease (Figure 5E, panel si/
p-circ; Figure S5E). Conversely, in all of the cases analyzed, no
effects were seen in the accumulation level of the circRNA (Fig-6 Cell Reports 31, 107641, May 12, 2020ures S5F–S5H). Notably, both protein and RNA levels derived
from p-lin transcription were unaltered by YTHDF3 depletion
(Figure 5E, panel si/p-lin; Figures S5I and S5J), indicating that
the effect was specific for translation deriving from the circRNA.
In line with these results, the overexpression of YTHDF3 resulted
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Figure 5. m6As Control circ-ZNF609 Translation
(A and B) Relative protein levels deriving from circ-ZNF609 translation expressed by p-circ (A) or p-lin (B) constructs and their mutant derivatives. Levels were
normalized over ACTB (p-circ) or ACTN1 (p-lin) protein level and expressed as relative quantities with respect to wild-type constructs set to 1; western blots are
shown in Figures S5A and S5B. n = 3.
(C and D) Representative western blots of the proteins derived from p-circ construct upon YTHDF1 (C, si-YF1) and YTHDF2 (D, si-YF2) knockdown. The levels of
YTHDF1 and YTHDF2 proteins are also shown. Relative quantities (RQs) are calculated with respect to si-scr treatment set to 1 and normalized over ACTN1 or
ACTB, used as loading controls (Ctrls). n = 3.
(E and F) Representative western blots of the proteins derived from either p-circ or p-lin constructs upon YTHDF3 (E) and eIF4G2 (F) knockdown (si-YF3 and si-
eIF4G2) or overexpression (YF3-OE and eIF4G2-OE); the levels of YTHDF3 and eIF4G2 proteins are also shown. RQs are calculated with respect to si-scr
treatment or Ctrl set to 1 and normalized over ACTB, used as the loading Ctrl. n = 3.
(G and H) Levels of RNA recovered from IP experiments upon overexpression of FLAG-tagged YTHDF3 (G) and eIF4G2 (H). Values are expressed as percentage
of input. ADAR and BCL2 mRNAs were used as positive Ctrls, whereas ATP5O and circ-PMS1 were used as negative ones in YTHDF3 and eIF4G2 IP,
respectively. The IP performed in HeLa cells transfected with an empty plasmid was used as Ctrl. Representative western blots showing the IP efficiency are
shown above each panel.
(A–H) The relative RNA quantity in the bars is represented as mean of the fold change with standard deviation. Dots represent the quantity relative to the
endogenous Ctrl for each biological replicate. The ratio of each sample versus its experimental Ctrl was tested by two-tailed Student’s t test. Student’s t test-
derived p values: *p < 0.05, **p < 0.01; ***p < 0.001.
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p-circ; Figure S5K), which was not justified by the increase in
RNA levels (Figure S5L).
Several factors were previously shown to be associated to
YTHDF3 and cap-independent translation (Zhang et al., 2019).
In particular, eIF3a and eIF3b were described to bind m6A resi-
dues and to initiate translation in a cap-independent manner
(Meyer et al., 2015; Yang et al., 2017). However, their downregu-
lation did not produce any observable effect on circ-ZNF609
translation (Figures S5M and S5N). Instead, eIF4G2 depletion
specifically affected the translation of the circRNA derived from
p-circ, but not of the linear transcript from p-lin (Figure 5F, panels
si/p-circ and si/p-lin; Figures S5O and S5P). In no casewas alter-
ation of the RNA levels observed (Figures S5Q and S5R).
Concordantly with YTHDF3, eIF4G2 overexpression also re-
sulted in an increased translation of p-circ (Figure 5F, panel
OE/p-circ; Figure S5S) without changes in RNA levels
(Figure S5T).
In order to further support their interaction with circ-ZNF609,
immunoprecipitation experiments were performed in HeLa cells,
demonstrating that both YTHDF3 and eIF4G2 physically asso-
ciate with the endogenous circ-ZNF609 (Figures 5G and 5H).
In conclusion, these results point out the relevance of both of
these factors in the translational control of circ-ZNF609.
DISCUSSION
Although the role of m6A modification has been well defined in
mRNA, no function for m6A in circRNA biogenesis and activity
has previously been shown. Here we demonstrate, using circ-
ZNF609 as a study case, that m6A modifications are able to
control two relevant aspects of circRNA metabolism: the first
correlates with the ability to regulate whether a specific exon
undergoes linear or back-splicing, whereas the second corre-
lates with that of tethering factors required for the cytoplasmic
function of the circRNAs, which in our case is the cap-indepen-
dent translation of circ-ZNF609.
The back-splicing reaction relies on the canonical splicingma-
chinery in a pathway that is alternative to the production of the
linear mRNA (Ashwal-Fluss et al., 2014). As in alternative splicing
(AS), cis- and trans-acting factors have been shown to modulate
the efficiency of back-splicing. RNA pairing between intronic se-
quences flanking the circularizing exon(s), such as Alu elements,
favors intron looping and brings the back-splicing junctions into
close proximity (Zhang et al., 2014). Specific activities have been
found to control such pairing and tomodulate back-splicing (Iva-
nov et al., 2015; Li et al., 2017). Furthermore, RNA-binding pro-
teins can induce looping by dimerization (Conn et al., 2015) or
by binding to specific motifs in the flanking introns (Errichelli
et al., 2017).
In our study, we add another layer of regulation where the
alternative choice between linear and circular splicing can be
influenced by epitranscriptomic modifications, providing a still-
missing link between m6A deposition and circRNA biogenesis.
Indeed, we show that for a class of circRNAs, the back-splicing
reaction requires the combined action of METTL3 and YTHDC1,
thus revealing an additional nuclear function for these factors. In
agreement with several evidences indicating that RNA process-8 Cell Reports 31, 107641, May 12, 2020ing and m6A installation are coupled, with methylation occurring
co-transcriptionally (Knuckles and B€uhler, 2018), we show that
for a class of circRNAmolecules the deposition ofm6A in specific
exonic regions on the primary transcript correlates with their
selection for the back-splicing reaction.
circ-ZNF609 was an interesting example to study because it
was described to promote cell proliferation and because its
levels correlate with the proliferative state of the cell. Indeed,
circ-ZNF609 increases in pathological conditions such as in
rhabdomyosarcoma, where proliferation predominates above
differentiation (Rossi et al. 2019). Interestingly, both METTL3
and YTHDC1 paralleled the increase of circ-ZNF609 in RNA-
seq data from rhabdomyosarcoma cell lines (Rossi et al. 2019),
and YTHDC1 further upregulated in rhabdomyosarcoma tumors
where circ-ZNF609 reaches 15-fold enrichment with respect to
primary myoblasts. Altogether, these data suggest that the
altered expression of METTL3 and YTHDC1 might contribute
to the observed circ-ZNF609 upregulation. Although METTL3 al-
terations are common in tumors and in most cases a positive
correlation between its expression levels and cell growth has
been demonstrated (Vu et al., 2017; Ianniello et al., 2019), limited
data are so far available for the m6A reader YTHDC1.
To date, it is known that METTL3 can act on nascent tran-
scripts: there is evidence that it can be recruited to the chro-
matin, where it can write m6A on the associated precursor
RNAs (Barbieri et al., 2017; Huang et al., 2019); moreover, it
can interact with specific mediators or RNA binding proteins
and induce m6A deposition in regions close to their binding
site (Patil et al., 2016; Knuckles et al., 2018). On the other
hand, how specific m6A consensus sites become preferentially
methylated on the nascent transcript has yet to be fully
ascertained.
Besides demonstrating the involvement of m6A in back-
splicing regulation, we also showed that m6A deposition on the
circularized exon is important for the cytoplasmic activity of
the circRNA under study, namely, translation. In fact, circ-
ZNF609 was previously shown to possess an ORF and to be
translated (Legnini et al., 2017).
Several data indicate a role of m6A in translation: mRNAs con-
taining m6A modification in their 50 UTR were shown to undergo
cap-independent translation upon specific cellular stress and to
bypass 50 cap-binding proteins to promote translation and to
control ribosome scanning (Coots et al., 2017; Meyer et al.,
2015; Zhou et al., 2018). Interestingly, eIF3 was identified as a
reader of m6A modifications in 50 UTR of mRNA: consistently,
genome-wide analysis showed that binding sites for this factor
were shown to overlap with m6A sites in 50 UTRs (Meyer et al.,
2015). However, unlike cap-independent translation of mRNA
with m6A-modified 50 UTRs, we show that circ-ZNF609 transla-
tion is insensitive to eIF3 and instead relies on the YTHDF3 and
eIF4G2 factors already described to drive cap-independent
translation and to promote protein synthesis from artificial circR-
NAs (Lo´pez de Quinto et al., 2001; Yang et al., 2017). Although
the mechanisms of cap-independent translation initiation have
been poorly understood, our results indicate that m6A residues
in translatable circRNAs can act as m6A-induced ribosome
engagement sites (MIRES), which promote cap-independent
translation (Knuckles et al., 2018).
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m6A. Because back-splicing can be considered as a form of AS,
the pathways and the elements regulating such a process are ex-
pected to be similarly diverse, mirroring the complexity of factors
that are involved in AS. Therefore, the finding of m6A playing a
crucial role in the back-splicing of a specific subset of circRNAs
is in line with the heterogeneity observed for AS. Moreover, in the
case of circ-ZNF609, our data also point to the existence of a
specific RNA factory that controls the fate and function of the
mature circRNA through modifications of the primary transcript.
In addition to the above, our findings also highlight further levels
of gene expression regulation controlled bym6A, thus increasing
the complexity and functions of transcripts deriving from a single
transcriptional unit.
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mouse monoclonal anti-Flag M2 Sigma-Aldrich Cat#F1804-1M, RRID:AB_259529
mouse monoclonal anti-FLAG M2-Peroxidase
(HRP)
Sigma-Aldrich Cat#A8592-2MG, RRID:AB_439702
rabbit monoclonal METTL3 Abcam Cat# ab195352, RRID:AB_2721254
rabbit polyclonal YTHDF1 Abcam Cat#ab99080, RRID:AB_10675362
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Subcloning efficiency DH5a competent cells Thermo Fisher Scientific cat#18265017
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DMEM-High glucose sigma-Aldrich cat#D6546
FBS sigma-Aldrich cat#F7524
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FGFb Millipore-MERCK cat#01-106
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Lipofectamine 2000 Thermo Fisher Scientific cat#11668019
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cOmplete, EDTA-free PIC Roche cat#11873580001
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RNase inhibitors Thermo Fischer Scientific Cat# EO0384
Dynabeads protein A/protein G Thermo Fischer Scientific cat#10015D
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VILO Superscript Thermo Fisher Scientific Cat# 11754050
Qiazol reagent QIAGEN Cat# 79306
PrimeScript RT Master Mix TakaraBio cat#RR036b
LiteAblot Extend Long Lasting Chemiluminescent
Substrate
EuroClone cat#EMP013001
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Critical Commercial Assays
In-Fusion HD Cloning Kit Clontech Cat#639649
Paris Kit Thermo Fisher Scientific cat#AM1921
Direct-Zol RNA MiniPrep Kit Zymo Research cat#R2050
Deposited Data
YTHDC1 RIP-Seq raw data see method details GEO: GSE74397
m6A RIP raw data see method details GEO: GSE85324
m6a-CLIP see method details GEO: GSE86336
METTL3 KD RNA sequencing raw data this paper GEO: GSE139076
YTHDC1 KD RNA sequencing raw data this paper GEO: GSE139076
Experimental Models: Cell Lines
Human male myoblasts (WT) Telethon Biobank N/A
RD ATCC CCL-136
RH4 see cell culture N/A
HeLa ATCC CCL-2
HEK293T ATCC CRL-3216
Oligonucleotides
DNA oligonucleotides used in this work are listed
in Table S2
this paper
siRNAs used in this work are listed in Table S2 this paper
Recombinant DNA
pcDNA3.1(-) Thermo Fisher Scientific N/A
p-circ see plasmid construction N/A
p-lin see plasmid construction N/A
c-D1 this paper N/A
c-D2 this paper N/A
l-D2 this paper N/A
c-D3 this paper N/A
c-Da.b this paper N/A
c-Da.b.2 this paper N/A
l-Da.b.2 this paper N/A
Flag-tagged YTHDF3 see plasmid costruction N/A
Flag-tagged EIF4G2 Sino Biological Inc. HG16622-CF
Software and Algorithms
ImageLab software Biorad https://www.bio-rad.com/it-it/product/
image-lab-software?ID=KRE6P5E8Z
Trimmomatic version 0.322.0.6 Bolger et al., 2014 http://www.usadellab.org/cms/?
page=trimmomatic
Cutadapt version 1.4.2 Martin, 2011 https://cutadapt.readthedocs.io/en/stable/
BWA version 0.7.10-r789 Li, 2013 http://bio-bwa.sourceforge.net/
CIRI version 2.0.6 Gao et al., 2018 https://sourceforge.net/projects/ciri/files/CIRI2/
R version 3.5.2 R Core Team, 2017 https://www.r-project.org/
edgeR version 3.24.3 Robinson et al., 2010 https://bioconductor.org/packages/release/bioc/
html/edgeR.html
Bedtools version 2.21.0 Quinlan and Hall, 2010 https://github.com/arq5x/bedtools2
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Irene
Bozzoni (irene.bozzoni@uniroma1.it)
Materials Availability
All unique/stable reagents generated in this study are available from the lead contact.
Data and Code Availability
All software used in this manuscript is listed in the Key Resources Table. Additional dedicated scripts developed for this work are
available upon request. The accession number for the high-throughput sequencing data reported in this paper is GEO : GSE139076.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture
Wild-type human primary myoblasts (Telethon Biobank) were obtained from a skeletal muscle biopsy from a 2-year-old male child.
No information available about their authentication. They were cultured in growth medium (GM): DMEM high glucose (Sigma-Aldrich,
Saint Louis, MO, USA), 10% FBS (Sigma-Aldrich), L-glutammine (Sigma-Aldrich) 2 mM, insulin (Sigma-Aldrich) 50 mg/ml, FGFb
(Millipore-Merck) 25 ng/ml, EGF (Corning, Corning, NY, USA) 1 ng/ml, penicillin-streptomycin 1 3 (Sigma-Aldrich). Human ERMS
RD cell line (embryonal rhabdomyosarcoma cell line from a female patient) and ARMS RH4 cells line (alveolar rhabdomyosarcoma
cell line from a female patient), HEK293T (human embryonal kidney cell line) as well as HeLa (Adenocarcinoma cell line from a female
patient) cells were cultured in DMEM (Sigma-Aldrich) supplemented with 10% FBS (Sigma-Aldrich), L-glutammine (Sigma-Aldrich)
2 mM and penicillin-streptomycin (Sigma-Aldrich). RD and RH4 cell lines were the same as Megiorni et al. (2016). and Rossi et al.
(2019) were previously authenticated and described in Megiorni et al. (2016). All cells were cultured at 37C in a humidified atmo-
sphere of 5% CO2.
Patient Biopsies
The tumor sample from a primary ERMSwas obtained at diagnosis before any treatment from children admitted to the Department of
Oncology at Alder Hey Children’s NHS Foundation Trust, Liverpool, United Kingdom. Institutional written informed consent was ob-
tained from the patient’s parents or legal guardians. The study underwent ethical review and approval according to the local institu-
tional guidelines (Alder Hey Children’s NHS Foundation Trust Ethics Committee, approval number 09/H1002/88).
METHOD DETAILS
Cell Transfection
Cells (150-200x103) were plated in 35mmplates and transfected 12hrs later with the siRNA against the target selected or the negative
control (final concentration 30nM) using 5 mL of Lipofectamine RNAiMAX Reagent (Thermo Fisher Scientific) and 300 mL of Opti-MEM
(Thermo Fisher Scientific). The medium was replaced 5-12hrs later. Cells were harvested 48hrs later. Exceptionally for the knock-
down of METTL3 cells were instead treated with a second siRNA pulse 48hrs after the first transfection. For actinomycin treatment,
cells depleted for YTHDC1 and METTL3 were split into two different plates and, after 12h, harvested or kept in their medium added
with actinomycin (5mg/ml) for 6.5h. Plasmids transfections were performed on untreated cells or, when required, 12hrs after the
siRNA transfections using 3 mL of Lipofectamine 2000 (Life technologies) in 300 mL of Opti-MEM (Thermo Fisher Scientific) with
100 ng-3 mg of DNA, added to a 35-mmplate with 150-200x103 cells in 2mL of medium.Mediumwas replaced 6-12hr after the trans-
fection and cells harvested for protein and RNA analyses 48hr later.
For the cells treated with either the siRNA against METTL3, plasmid transfection was performed 24hrs after the siRNA transfection.
Protein Analyses
Cells were harvested with 50-150 mL of Protein Extraction Buffer (100 mM Tris pH7.5, EDTA 1mM, SDS 2%, PIC1X (Complete, EDTA
free, Roche) and incubated 10min on ice, then incubated on a rotator for 30min at 4Cand centrifuged at 13000xrpm for 10min at 4C.
The supernatant was transferred to a clean tube, used or stored at 80C. Total protein concentration was measured through the
Bradford reagent (Bio-Rad Protein Assay) following manufacturer’s instructions.
25-50 mg of proteins were loaded on 4%–12% bis-tris-acrylamide gel (Life technologies) and transferred to a nitrocellulose mem-
brane. The membrane was blocked in 5%milk and then hybridized with specific antibodies for 2hrs-o.n. at room temperature. After
three washes in TBST, the filter was hybridized with the corresponding secondary antibody, if required, for one hour at room
temperature.Cell Reports 31, 107641, May 12, 2020 e3
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Max Western ECL Blotting Substrate (BioRad) using ChemiDoc MP System and images were analyzed using Image Lab Software
(BioRad).
RNA Analysis
Cell fractionation was carried out thanks to Ambion PARIS kit according to manufacturer’s protocol.
Nuclear, cytoplasmic or total RNA in this study was extracted with Quiazol reagent and the Direct-zol RNA Miniprep (Zymo
Research) kit according to the manufacturer’s specifications. When needed, DNase treatment was performed (Thermo Fisher
Scientific).
Reverse transcription reactions of this study were performed with PrimeScript RT Master Mix (Takara Bio) on 100-500ng of total
RNA in a 10 mL reaction. QPCR analyses in this study were performed with 6-15ng equivalent of cDNA, 7.5 mL of 2X SYBRMastermix
(QIAGEN), 1.5 mL of 5 mMprimers and water to a final volume of 15 ml. DNA amplification (40 cycles of 95C for 30 s, 55C for 30 s and
72C for 30 s, followed by melting curve analysis) was monitored with an ABI 7500 Fast or StepOnePlus System qPCR instrument.
PCR reactions were performedwith 0.3 mL ofMytaq DNA polymerase (Bioline) in 25 mLwater with 5 mL of 5X reaction buffer, 6-15ng
of cDNA, 2.5 mL of 5 mMprimers. Reaction was carried out for 30 cycles at 95C for 25 s, 55C for 25 s, 72C for 25 s. 5 mL of PCRwere
run on 2% agarose gel. All primers used in this study are reported below.
Relative RNA quantity was calculated as the fold change (DDCt) with respect to the experimental control sample set as 1. Dots
represent the quantity relative to the endogenous control (DCt) and normalized over ACTN1 or ACTB or GAPDH mRNA. The ratio
of each sample versus its experimental control was tested by two-tailed Student’s t test. One asterisk indicates a Student’s t
test-derived p value < 0.05, two asterisks indicate a p value < 0.01, and three asterisks a p value < 0.001. For dot-blot analysis,
RNA samples were denatured at 95C for 5 min and loaded onto nitrocellulose membrane using the Bio-Dot Apparatus (Biorad).
The membrane was cross-linked twice at 120,000 microjoules/cm2, washed 5 min with PBS-T solution, blocked in 5% milk and
then hybridized with m6A-antibody overnight at room temperature. After three washes in PBS-T, the filter was hybridized with the
rabbit secondary antibody for one hour at room temperature.
Detection was performedwith Clarity MaxWestern ECLBlotting Substrate (BioRad) using ChemiDocMPSystem and images were
analyzed using Image Lab Software (BioRad).
Plasmids Construction
P-circ and the p-lin construction was already described by Legnini et al. (2017). The plasmids in that study are named as ‘‘p-circ3xF’’
and ‘‘p-lin-3xF,’’ respectively.
We obtained the c-D1 mutant by inverse PCR followed by ligation, from p-circ and p-lin, respectively, with D1_fw and D1_rev oli-
gos; the c-D2 and the l-D2 mutants with D2_fw and D2_rev oligos; the c-D3 mutant with D3_fw and D3_rev oligos.
In order to obtain c-Dab, c-Dab2 and l-Dab2 mutants, p-circ, p-lin, c-D2 or l-D2, respectively, were first linearized by inverse PCR
with Dab_Inverse_fw and Dab_Inverse_rev oligos. The insert containing the desired mutations was obtained by annealing ssDNA oli-
gosDab_Insert_fw and Dab_Insert_rev; the insert was introduced in the linearized vectors with the In-FusionHDCloning (Clontech)
kit, according to manufacturer’s instructions. The plasmids were amplified in DH5a competent cells (Thermo Fisher Scientific)
The construct overexpressing Flag-tagged YTHDF3 was kindly provided by Dr. Chuan He group. The construct overexpressing
Flag-tagged EIF4G2 was bought from Sino Biological Inc. [HG16622-CF].
M(6)A CLIP
M6A CLIP was performed according to the protocol described by Linder et al. (2015) with some modifications. Briefly, total RNA was
purified from HeLa cells, 20 mg of RNA were diluted in IP buffer supplemented with RNase Inhibitor (Thermo Fisher Scientific) and
incubated with 5 mg of anti-m6A antibody for 2hrs at 4C rotating head over tail and crosslinked, 10% of the solution was saved
to be used as input, the leftover incubated with protein A/protein G dynabeads (Thermo Fisher Scientific) for 2hrs at 4C. Bead-bound
antibody-RNA complexes werewashed and recovered. After phenol-chloroform extraction and precipitation, RNAwas resuspended
in 30 mL and 7 mL were reverse-transcribed with VILO Superscript (Thermo Fisher Scientific) in a 10 mL reaction. q-PCR was per-
formed to evaluate targets enrichment.
Immunoprecipitation
HeLa cells (600X103) were transfected in a 35mm plate with either a control plasmid or with the plasmid overexpressing the flag-
tagged protein of interest and transferred to a 10cm plate 12hrs later. 48hrs later, cells were washed twice with PBS buffer and
scraped with an IP buffer (20mM TrisHCl pH7.5, 150mM NaCl, 15mM MgCl2, 0.5% NP40, 1mM EDTA, DTT 1 mM, PIC (Roche)
1x. Lysates were incubated for 5min on ice and then passed through a 21G needle.
Lysates were spun down for 15min at 4C at 13000 rpm and the supernatants were collected. 500ug-1mg of extract quantified
through a Bradford assay were diluted in 1,5 mL of IP buffer and incubated with 10 mg of tRNA and 60mL Anti-FLAG Magnetic Beads
(Sigma M8823) (washed twice with the Ip buffer) and incubated 3hrs-overnight at 4C on a wheel. The 10% of the used extract was
saved to be used as input. The beads were recovered through a magnetic rack and washed four times with 1ml wash buffer1 (20mM
TrisHCl pH7.5, 200mMNaCl, 15mM,MgCl2, 0.5%NP40, 1mMEDTA). Samples collected after the last wash were divided for proteine4 Cell Reports 31, 107641, May 12, 2020
Article
ll
OPEN ACCESSor RNA analysis. The proteins fractionwas resuspended in LDS 1X buffer (Biorad) addedwith DTT 1mM, heated at 95C for 10min and
loaded for western blot analyses. The RNAwas extracted and reverse transcribedwith VILOSuperscript (Life Technologies) for qPCR
analyses.
RNA-Seq
Total RNA was extracted from two biological replicates of HeLa cells treated with siRNA against either YTHDC1 or METTL3. Two
biological replicates of the control sample were produced for the knock-down of YTHDC1 and one for the knock-down of METTL3.
The RNA library was produced using Truseq Stranded Total RNA kit with Ribo-Zero H/M/R treatment (Illumina) and sequenced on an
Illumina Novaseq6000 Sequencing system. An average of about 33.5 million 101 nucleotides long paired-end read pairs were pro-
duced for each sample.
Bioinformatic Analyses
YTHDC1 RIP-Seq (Roundtree et al., 2017) raw data (input and IP Ribo(-) from HeLa cells) and m6A RIP (Zhou et al., 2017) (input,
eluate, and supernatant from HeLa cells) were downloaded from GEO (GSE74397, GSE85324). Biological replicates from m6A-
RIP were pooled to improve circRNA detection sensitivity.
Trimmomatic (Bolger et al., 2014) and Cutadapt (Martin, 2011) were used to remove adaptor sequences in reads from knock-down
and RIP-Seq experiments, respectively; minimum read length after trimming was set to 20. Reads were then aligned to the human
reference genome (GRCh38) using BWA-MEM (Li, 2013) with -T 19 option. circRNA detection in each sample was then carried out
using CIRI2 software (Gao, Zhang and Zhao, 2018), which is able to identify circRNAs by searching for reads which map to back-
splicing junctions. To identify circRNA host genes, the program was provided with Ensembl 90 gene annotation (Zerbino et al.,
2018). For each back-splicing event found, CIRI2 reports the number of reads mapping to the back-splicing junction and on the cor-
responding linear splicing junctions, calculated summing all the reads mapping linearly on both the splice junctions involved in back-
splicing; the latter are not reported if no read is assigned to the back-splicing junction, even if the circular RNA is detected in other
samples. In order to count the reads mapping to linear splicing sites in samples in which no reads where mapped to corresponding
back-splicing junctions detected in other samples, alignment files from each sample were modified by adding reads mapping to
circRNAs found only in other samples and CIRI2 was rerun on these files. Putative back-splicing events that were spanning two
non-overlapping genes, which were likely to be due to mapping errors, were excluded from further analysis.
Reads mapping to back-splicing junctions and to their cognate linear splicing junctions were converted to Count Per Million (CPM)
values using edgeRR package (Robinson et al., 2010) and used for circRNA and linear RNA quantification. To evaluate the differential
expression of circRNAs between knock-down and si-scramble conditions, we provided the edgeR software with the read counts of
both the back-splicing events and their cognate linear splicing events. Events not having 2 ormore counts in at least one sample were
not tested for differential expression. Model fitting and testing was performed using the glmFIT and glmLRT functions. Given the low
number of reads used for testing, we decided to use p value instead of false discovery rate to select for differentially expressed
events, setting the significance threshold value to 0.1.
CircRNAs enriched in YTHDC1 RIP were defined as those with a fold change over the input of at least 2. CircRNAs exclusively
precipitated by m6a RIP were defined as those having at least 2 counts in the eluate and none in the supernatant; those having at
least 2 counts in the supernatant and none in the eluate were classified as non-precipitated.
M6A antibody-enriched RNA regions and precise consensusm6A sites identified via m6a-CLIP on total RNA from nucleoplasm and
cytoplasm, and PolyA+ RNA from cytoplasm of HeLa cells (Ke et al., 2017) were downloaded from GEO (GSE86336). Bedtools suite
(Quinlan and Hall, 2010) was used to search for overlaps between m6A antibody-enriched RNA regions and exonic regions from pro-
tein-coding transcripts included within circRNAs genomic coordinates.
QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical tests, statistical significance for comparisons ofmeans and sample numbers are disclosed in respective Figure Legends.
Statistical analysis of bioinformatics data are described in details in the ‘‘Method Details’’ section.Cell Reports 31, 107641, May 12, 2020 e5
